Browsing by Subject "community engagement"

Now showing 1 - 3 of 3
  • Thumbnail Image
    ItemOpen Access
    An innovative educational program for addressing health disparities in translational cancer research.
    (Journal of clinical and translational science, 2020-11) Oldham, Carla E; Gathings, MJ; Devi, Gayathri R; Patierno, Steven R; Williams, Kevin P; Hough, Holly J; Barrett, Nadine J
    North Carolina Central University (NCCU) and Duke Cancer Institute implemented an NCI-funded Translational Cancer Disparities Research Partnership to enhance translational cancer research, increase the pool of underrepresented racial and ethnic group (UREG) researchers in the translational and clinical research workforce, and equip UREG trainees with skills to increase diversity in clinical trials. The Cancer Research Education Program (C-REP) provided training for UREG graduate students and postdoctoral fellows at Duke and NCCU. An innovative component of C-REP is the Translational Immersion Experience (TIE), which enabled Scholars to gain knowledge across eight domains of clinical and translational research (clinical trials operations, data monitoring, regulatory affairs, UREG accrual, biobanking, community engagement, community outreach, and high-throughput drug screening). Program-specific evaluative metrics were created for three broad domains (clinical operations, basic science/lab research, and population-based science) and eight TIE domains. Two cohorts (n = 13) completed pre- and post-surveys to determine program impact and identify recommendations for program improvement. Scholars reported statistically significant gains in knowledge across three broad domains of biomedical research and seven distinct areas within TIE. Training in translational research incorporating immersions in clinical trials operation, biobanking, drug development, and community engagement adds value to career development of UREG researchers.
  • Thumbnail Image
    ItemOpen Access
    Perspectives on Inflammatory Breast Cancer (IBC) Research, Clinical Management and Community Engagement from the Duke IBC Consortium.
    (Journal of Cancer, 2019-01) Devi, Gayathri R; Hough, Holly; Barrett, Nadine; Cristofanilli, Massimo; Overmoyer, Beth; Spector, Neil; Ueno, Naoto T; Woodward, Wendy; Kirkpatrick, John; Vincent, Benjamin; Williams, Kevin P; Finley, Charlotte; Duff, Brandi; Worthy, Valarie; McCall, Shannon; Hollister, Beth A; Palmer, Greg; Force, Jeremy; Westbrook, Kelly; Fayanju, Oluwadamilola; Suneja, Gita; Dent, Susan F; Hwang, E Shelley; Patierno, Steven R; Marcom, P Kelly
    Inflammatory breast cancer (IBC) is an understudied and aggressive form of breast cancer with a poor prognosis, accounting for 2-6% of new breast cancer diagnoses but 10% of all breast cancer-related deaths in the United States. Currently there are no therapeutic regimens developed specifically for IBC, and it is critical to recognize that all aspects of treating IBC - including staging, diagnosis, and therapy - are vastly different than other breast cancers. In December 2014, under the umbrella of an interdisciplinary initiative supported by the Duke School of Medicine, researchers, clinicians, research administrators, and patient advocates formed the Duke Consortium for IBC to address the needs of patients in North Carolina (an ethnically and economically diverse state with 100 counties) and across the Southeastern United States. The primary goal of this group is to translate research into action and improve both awareness and patient care through collaborations with local, national and international IBC programs. The consortium held its inaugural meeting on Feb 28, 2018, which also marked Rare Disease Day and convened national research experts, clinicians, patients, advocates, government representatives, foundation leaders, staff, and trainees. The meeting focused on new developments and challenges in the clinical management of IBC, research challenges and opportunities, and an interactive session to garner input from patients, advocates, and community partners that would inform a strategic plan toward continuing improvements in IBC patient care, research, and education.
  • Thumbnail Image
    ItemOpen Access
    The Community-Engaged Lab: A Case-Study Introduction for Developmental Science.
    (Frontiers in psychology, 2021-01) Liu, Judy; Partington, Scott; Suh, Yeonju; Finiasz, Zoe; Flanagan, Teresa; Kocher, Deanna; Kiely, Richard; Kortenaar, Michelle; Kushnir, Tamar
    Due to the closing of campuses, museums, and other public spaces during the pandemic, the typical avenues for recruitment, partnership, and dissemination are now unavailable to developmental labs. In this paper, we show how a shift in perspective has impacted our lab's ability to successfully transition to virtual work during the COVID-19 shut-down. This begins by recognizing that any lab that relies on local communities to engage in human research is itself a community organization. From this, we introduce a community-engaged lab model, and explain how it works using our own activities during the pandemic as an example. To begin, we introduce the vocabulary of mission-driven community organizations and show how we applied the key ideas of mission, vision, and culture to discussions of our own lab's identity. We contrast the community-engaged lab model with a traditional bi-directional model of recruitment from and dissemination to communities and describe how the community-engaged model can be used to reframe these and other ordinary lab activities. Our activities during the pandemic serve as a case study: we formed new community partnerships, engaged with child "citizen-scientists" in online research, and opened new avenues of virtual programming. One year later, we see modest but quantifiable impact of this approach: a return to pre-pandemic diversity in our samples, new engagement opportunities for trainees, and new sustainable partnerships. We end by discussing the promise and limitations of the community-engaged lab model for the future of developmental research.